tiprankstipranks
Trending News
More News >
China Tobacco International (HK) Co Ltd (HK:6055)
:6055
Hong Kong Market

China Tobacco International (HK) Co (6055) AI Stock Analysis

Compare
4 Followers

Top Page

HK:6055

China Tobacco International (HK) Co

(6055)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 4o)
Rating:58Neutral
Price Target:
HK$36.00
â–²(0.73% Upside)
The overall stock score of 58 reflects a strong financial performance, but is weighed down by bearish technical indicators and a high valuation. The company's robust revenue and profit growth are positive, but cash flow challenges and a high P/E ratio suggest caution. The lack of earnings call data and corporate events limits additional insights.
Positive Factors
Revenue Growth
Consistent revenue growth indicates robust demand for products and effective market strategies, supporting long-term business expansion.
Profitability
Improved profitability through better cost management enhances financial health and provides a cushion for future investments and challenges.
Leverage Position
A stable leverage position reflects prudent financial management, reducing risk and enhancing the company's ability to invest in growth opportunities.
Negative Factors
Cash Flow Challenges
Reduced operating cash flow can strain liquidity, limiting the company's ability to fund operations and invest in growth without external financing.
Equity Ratio
A lower equity ratio suggests higher financial risk due to increased reliance on debt, potentially impacting long-term financial stability.
Operational Efficiency
Lower operational efficiency margins indicate potential areas for improvement in cost control and productivity, affecting profitability.

China Tobacco International (HK) Co (6055) vs. iShares MSCI Hong Kong ETF (EWH)

China Tobacco International (HK) Co Business Overview & Revenue Model

Company DescriptionChina Tobacco International (HK) Company Limited engages in the trade of tobacco products. The company operates through Tobacco Leaf Products Export Business, Tobacco Leaf Products Import Business, Cigarettes Export Business, and New Tobacco Products Export Business segments. The Tobacco Leaf Products Export Business segment procures and exports tobacco leaf products to cigarette manufacturers and authorized purchasing agents of cigarette manufacturers. The Tobacco Leaf Products Import Business segment imports tobacco leaf products to mainland China. The Cigarettes Export Business segment exports cigarettes to duty-free outlets and cigarettes wholesalers. The New Tobacco Products Export Business segment exports new tobacco products to retailers, cigarettes wholesalers, and independent third parties. It operates in the People's Republic of China, Indonesia, Hong Kong, the Philippines, Vietnam, Singapore, Barzil, and internationally. The company was incorporated in 2004 and is headquartered in Kowloon, Hong Kong. China Tobacco International (HK) Company Limited is a subsidiary of China Tobacco International Group Limited.
How the Company Makes MoneyChina Tobacco International (HK) Co generates revenue primarily through the sale of its tobacco products in international markets. The company's revenue model is largely driven by the import and export of cigarettes, which are sold to various distributors and retailers worldwide. Key revenue streams include direct sales to foreign markets, partnerships with local distributors, and licensing agreements that allow other companies to produce and sell its brands. Additionally, the company benefits from economies of scale due to its affiliation with the China National Tobacco Corporation, which provides it with access to a vast tobacco supply and resources for efficient production and distribution. Market demand for tobacco products, pricing strategies, and regulatory factors in different regions also significantly influence the company's earnings.

China Tobacco International (HK) Co Financial Statement Overview

Summary
China Tobacco International (HK) Co presents a robust financial position with strong revenue and profit growth. The balance sheet reflects stability with a stable leverage position and improved ROE. However, cash flow challenges persist, requiring attention to maintain financial health.
Income Statement
85
Very Positive
The company has demonstrated strong revenue growth, with a 10.4% increase from 2023 to 2024. Gross profit margin improved to 10.54% in 2024, indicating better cost management. Net profit margin rose to 6.53%, showing enhanced profitability. However, EBIT and EBITDA margins were slightly lower at 10.25% and 9.66% respectively, suggesting room for operational efficiency improvement.
Balance Sheet
78
Positive
The company's debt-to-equity ratio increased from 1.00 in 2023 to 0.99 in 2024, indicating a stable leverage position. Return on equity (ROE) improved to 28.41%, reflecting effective use of equity. The equity ratio decreased to 30.61%, highlighting increased reliance on liabilities. Overall, the balance sheet is strong but could benefit from a higher equity ratio.
Cash Flow
70
Positive
The cash flow statement shows mixed results, with a significant drop in operating cash flow from 2023 to 2024. Free cash flow growth rate is unavailable due to zero free cash flow in 2024, raising concerns about cash generation capabilities. The company needs to enhance its cash flow management to support growth and operational needs.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue14.69B13.07B11.84B8.32B8.06B3.48B
Gross Profit1.36B1.38B1.09B793.57M400.56M130.72M
EBITDA1.24B1.26B1.08B750.92M738.91M112.75M
Net Income916.75M853.74M598.77M374.90M702.83M106.12M
Balance Sheet
Total Assets10.00B9.82B6.74B6.37B4.77B3.80B
Cash, Cash Equivalents and Short-Term Investments3.98B2.86B2.33B1.79B1.66B1.63B
Total Debt2.55B2.98B2.49B2.11B1.31B25.53M
Total Liabilities6.30B6.63B4.05B4.13B2.78B2.06B
Stockholders Equity3.50B3.01B2.49B2.02B1.76B1.75B
Cash Flow
Free Cash Flow2.00B610.44M501.77M-390.07M30.13M31.94M
Operating Cash Flow2.01B629.44M517.91M-383.80M30.97M42.83M
Investing Cash Flow-653.77M-459.99M-1.70B11.21M12.34M65.72M
Financing Cash Flow-753.82M-164.01M-27.05M512.66M-43.33M-156.81M

China Tobacco International (HK) Co Technical Analysis

Technical Analysis Sentiment
Negative
Last Price35.74
Price Trends
50DMA
35.16
Negative
100DMA
38.59
Negative
200DMA
34.46
Negative
Market Momentum
MACD
-0.11
Positive
RSI
41.58
Neutral
STOCH
15.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6055, the sentiment is Negative. The current price of 35.74 is above the 20-day moving average (MA) of 34.72, above the 50-day MA of 35.16, and above the 200-day MA of 34.46, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 41.58 is Neutral, neither overbought nor oversold. The STOCH value of 15.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6055.

China Tobacco International (HK) Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
58
Neutral
HK$23.34B25.4628.61%1.44%14.77%16.77%
58
Neutral
HK$67.70B55.405.06%2.03%15.05%-30.92%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:6055
China Tobacco International (HK) Co
33.74
11.76
53.50%
HK:6969
Smoore International Holdings Limited
10.93
-1.50
-12.07%

China Tobacco International (HK) Co Corporate Events

China Tobacco International (HK) Strengthens Board Governance With New Lead INED and Committee Appointment
Dec 31, 2025

China Tobacco International (HK) Company Limited has designated existing independent non-executive director (INED) Chow Siu Lui as lead independent non-executive director, effective 31 December 2025, to strengthen corporate governance. Chow, who already chairs the audit and remuneration committees and sits on the nomination and strategic development committees, will serve as a key communication channel between INEDs, the board and shareholders, without assuming additional executive or managerial responsibilities. The firm has also appointed INED He Junhua as a member of the nomination committee from the same date, ensuring the committee includes a director of a different gender. These board changes are being implemented to align with the amended Corporate Governance Code that took effect in July 2025 and are aimed at enhancing board effectiveness, diversity and overall governance standards at the company.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International (HK) Details Board and Committee Structure
Dec 31, 2025

China Tobacco International (HK) Company Limited has announced the current composition of its board of directors and the allocation of roles across its five key board committees. The board is chaired by non-executive director Shao Yan and includes four executive directors and four independent non-executive directors, reflecting a governance structure with a significant independent component. The company has detailed the membership of its Audit, Nomination, Remuneration, Connected Transactions Control and Strategic Development Committees, designating independent director Chow Siu Lui as lead independent director and chair of both the Audit and Remuneration Committees, while Shao Yan chairs the Nomination and Strategic Development Committees and Wang Xinhua leads the Connected Transactions Control Committee. The announcement underlines the group’s emphasis on board oversight, risk management and strategic planning, which is closely watched by investors in light of regulatory scrutiny and governance expectations for Hong Kong-listed state-linked enterprises.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International (HK) Tightens Governance With Revised Nomination Committee Mandate
Dec 31, 2025

China Tobacco International (HK) Company Limited has formalised updated terms of reference for its Nomination Committee, specifying that the committee will be composed of at least three directors, with a majority being independent non-executive directors and at least one member of a different gender, and chaired by either the board chairman or an independent non-executive director. The committee is tasked with overseeing board structure and composition, identifying and recommending director candidates, assessing the independence of non-executive directors, guiding succession planning for key leadership roles, supporting regular board performance evaluations, and reviewing its own effectiveness annually, underscoring the company’s efforts to strengthen corporate governance and board oversight for stakeholders.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International Extends Key Tobacco Leaf Supply and Service Deals With Alliance One
Dec 31, 2025

China Tobacco International (HK) Company Limited has renewed a series of framework agreements governing the sale and purchase of tobacco leaves and related services with Alliance One International and its Brazilian subsidiary, Alliance One Brazil, both of which are connected persons at the subsidiary level via their 49% interest in CBT. The parties signed new 2025 extension agreements to prolong the existing sales and purchase frameworks for three years from 1 January 2026 to 31 December 2028 and to formalise additional terms for procuring services related to the processing and production of tobacco leaf products, while keeping other key terms and pricing policies unchanged. As these arrangements involve connected parties under Hong Kong listing rules, the renewed agreements are classified as continuing connected transactions, underscoring the importance of Alliance One Group as a strategic partner in the group’s tobacco leaf supply chain and the company’s ongoing reliance on this relationship for stable sourcing and processing capacity.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

China Tobacco International Expands Global Cigar Distribution
Nov 6, 2025

China Tobacco International (HK) Company Limited has entered into an exclusive distribution agreement with China Tobacco Anhui for the global market distribution of ‘Wangguan’ cigars, excluding Mainland China. This agreement extends the company’s distribution scope beyond its previous duty-free markets, marking a significant step in establishing a global sales platform for Chinese cigars. The move is expected to enhance the company’s international influence and competitiveness in the cigar market.

The most recent analyst rating on (HK:6055) stock is a Hold with a HK$40.00 price target. To see the full list of analyst forecasts on China Tobacco International (HK) Co stock, see the HK:6055 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025